Teva Inks $2.55M Deal To Settle 401(k) Fee Suit
Teva Pharmaceuticals USA Inc. has agreed to pay nearly $2.6 million to wrap up a proposed ERISA class action accusing it of including unnecessarily costly investments in a 401(k) plan that...To view the full article, register now.
Already a subscriber? Click here to view full article